Abbott acquires Exact Sciences
Abbott agreed to acquire Exact Sciences. Reported deal value: $21B. Status: Announced. Sector: molecular diagnostics. Target headquarters context: Madison, Wisconsin, United States.
This page summarizes publicly available information about the transaction as of 2026-01-20. Figures and status may change as filings and press coverage update.
Shares contributed positively during the quarter after Abbott announced a definitive all-cash agreement to acquire Exact Sciences for approximately $21 billion in equity value, reflecting a meaningful premium and driving the stock higher.' Story Continues Exact Sciences : Among Billionaire George Soros’ Small-Cap Stocks with Huge Upside Potential Exact Sciences Corporation is not on our list of 30 Most Popular Stocks Among Hedge Funds
Deal timeline
This transaction is classified in molecular diagnostics with a reported deal value of $21B. Figures and status may change as sources update.